Staar Surgical
This article was originally published in The Gray Sheet
Executive Summary
Ophthalmic products company is evaluating a cash offer to acquire 51-100% of its outstanding common stock at $15 per share from an unnamed entity "whose principals have not been disclosed," the firm reports in a June 28 release. Monrovia, California-based Staar makes minimally invasive devices for refractive, cataract and glaucoma surgery including foldable intraocular lenses